AstraZeneca Pharma India Ltd. — Board/Management Information 2023

Jul 31, 2023

==> picture [452 x 78] intentionally omitted <==

July 31, 2023

The Manager- Listing

BSE Limited

Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai – 400 001

The Manager- Listing

National Stock Exchange of India Limited

Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E), Mumbai – 400 051

Dear Sir(s),

Sub: Information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you on the change in role of Mr. Atul Tandon, Business Unit Head – Oncology. He will be transitioning from the said role with effect from close of business hours on July 31, 2023, as he takes up another responsibility within AstraZeneca group. In the interim, the Oncology Business Unit of the Company will be managed by Mr. Ayush Kumar Agarwal, who is currently the Director - Commercial Excellence.

Kindly take the above information on record.

For AstraZeneca Pharma India Limited

MANAS Digitally signed by MANASA RAMA A RAMA Date: 2023.07.31 15:53:36 +05'30' Manasa. R Company Secretary

==> picture [453 x 64] intentionally omitted <==